390 results
Page 8 of 20
10-K
EX-31.1
675242
12 Feb 18
Annual report
12:00am
10-K
EX-10.27
ircqua
12 Feb 18
Annual report
12:00am
10-K
EX-10.30
02wk1lyln4rq
12 Feb 18
Annual report
12:00am
10-K
EX-10.54
cd0vw5zh1gp 720nnis
12 Feb 18
Annual report
12:00am
10-K
EX-10.31
riudkpooh
12 Feb 18
Annual report
12:00am
10-K
EX-31.2
uv7 0baocgng
12 Feb 18
Annual report
12:00am
10-K
EX-10.23
g6zd2sdi
12 Feb 18
Annual report
12:00am
10-K
EX-10.44
ndkqsqg xolg9ld4t
12 Feb 18
Annual report
12:00am
10-K
EX-10.56
1np51sba6h k6t
12 Feb 18
Annual report
12:00am
10-K
EX-10.65
6igmcfc3e
12 Feb 18
Annual report
12:00am
6-K
EX-99.1
djbnm4ty7aiwkl
27 Nov 17
Teva Announces New Organization Structure and Leadership Changes
12:00am
6-K
EX-99.1
al0ql7j 03
6 Oct 16
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
12:00am
6-K
EX-99.1
s03n0ze6elz7
20 Sep 16
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
12:00am
6-K
EX-4.2
2q5v6ln2td2lqonmh
25 Jul 16
Current report (foreign)
12:00am
424B5
79vz99i
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
t2s4e7gq a4z
13 Jul 16
First Amendment to Master Purchase Agreement
12:00am
6-K
2t7ko
13 Jul 16
Current report (foreign)
12:00am